Company intelligence / Profile preview

Lihua Li

Linhai, Zhejiang, China

Ownership: Private
Development stage: Other

Overview

Zhejiang Lihua Pharmaceutical is a leading Chinese pharmaceutical company specializing in the development and manufacture of steroid hormone APIs and intermediates. Founded in 1996 and headquartered in Linhai, Zhejiang, the company is a major global supplier of corticosteroid products such as hydrocortisone, prednisolone, and dexamethasone. Lihua Pharmaceutical operates large-scale GMP-compliant manufacturing facilities and provides contract manufacturing services to global pharmaceutical partners. In 2015, the company was acquired by Tianjin Lisheng Pharmaceutical, further strengthening its position in the global corticosteroid market.

Therapeutic areas: EndocrinologyImmunologyDermatology
Modalities: Small molecule
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Lihua Li.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lihua Li.

Explore the full profile